Diatech Logo Diatech Retina Logo Diatech Mobile Logo Diatech Mobile Retina Logo Diatech Sticky Logo Diatech Sticky Logo Retina
  • Home
  • Unternehmen
  • Produkte
    • Extraktion
      • Linie Helix
    • Sequencing
      • Linie Response
      • Linie MSI
      • Linie Myriapod NGS
      • Linie Myriapod NGS dry
    • Gene Expression
      • Linie RealQuant
    • Massen-spektronomie
      • Linie Myriapod
    • Real Time PCR
      • Linie Easy
      • Linie Easy PGX
      • Linie Easy SARS-CoV-2
      • Linie Easy Respiratory Panel
    • Download-Bereich
      • Alle Produktbroschüre
  • Medien
    • Nachrichten
    • Veranstaltungen
    • Presseschau
    • Pressemitteilungen
    • Newsletter
    • Shooting cancer
  • Veröffentlichungen
  • Karriere
  • Kontakt
  • IT
  • EN
  • DE
7 12, 2020

Annamaria Siggillino et. al., Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR

Diatech Pharmacogenetics 2020-12-07T12:32:21+00:00
Mehr erfahren
21 07, 2020

Umberto Malapelle et. al., Predictive molecular pathology in the time of coronavirus disease

Diatech Pharmacogenetics 2020-07-21T14:11:03+00:00
Mehr erfahren
29 06, 2020

Marco Mammana et. al., Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis

Diatech Pharmacogenetics 2020-11-03T14:34:17+00:00
Mehr erfahren
16 05, 2020

Alessandro Parisi et. al., Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

Diatech Pharmacogenetics 2020-11-03T15:11:22+00:00
Mehr erfahren
7 05, 2020

Elisabetta Zulato et. al., Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer

Diatech Pharmacogenetics 2020-11-03T15:24:44+00:00
Mehr erfahren
31 07, 2019

Sergio Migliore et al., Large-scale PRNP genotyping of small ruminants using an automated high-throughput MALDI-TOF MS assay.

Marco Amadio 2019-07-31T09:07:37+00:00
Mehr erfahren
2 05, 2019

Paola Bordi et al., From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC

Marco Amadio 2019-05-02T09:45:38+00:00
Mehr erfahren
29 04, 2019

Michela Notarangelo et al., Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood

Marco Amadio 2019-04-29T09:51:27+00:00
Mehr erfahren
11 04, 2019

Enrico Mini et al., RNA sequencing reveals PNN and KCNQ1OT1as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

Marco Amadio 2019-04-11T11:26:55+00:00
Mehr erfahren
14 02, 2019

Lorenza Rimassa et al., Phase 2 study of tivantinib and cetuximab in KRAS wild-type metastatic colorectal cancer patients with acquired resistance to EGFR inhibitors and emergence of MET overexpression: lesson learned for future trials with EGFR/MET dual inhibition

Marco Amadio 2019-02-14T09:32:18+00:00
Mehr erfahren
1 2 Next

Diatech Pharmacogenetics srl
Via Ignazio Silone, 1/B
60035 Jesi (AN) – Italy
Tel. +39 0731 213243
fax +39 0731 213239
P.Iva e CF 02483840423
CUU M5UXCR1

>>
Die auf dieser Webseite genannten
Namen und Marken gelten als gesetzlich geschützt, auch wenn dies nicht ausdrücklich angegeben ist.
  • Unternehmen
  • Produkte
  • Veröffentlichungen
  • Nachrichten
  • Pressemitteilungen
  • Presseschau
  • Karriere
  • Kontakt
Copyright 2020 Diatech Pharmacogenetics | All Rights Reserved | Privacy policy | credits
FacebookLinkedinYouTubeTwitter